| Blood kinetics of Ebola virus in survivors and nonsurvivors. IG Lanini S, Portella G, Vairo F, Kobinger GP, Pesenti A, Langer M, Kabia S ... Journal of Clinical Investigation 125 (12), 4692-8, 2015 | 112 | 2015 |
| Inflammatory and humoral immune response during Ebola virus infection in survivor and fatal cases occurred in Sierra Leone during the 2014–2016 outbreak in West Africa F Colavita, M Biava, C Castilletti, S Lanini, R Miccio, G Portella, F Vairo, ... Viruses 11 (4), 373, 2019 | 41 | 2019 |
| Severe refractory asthma: current treatment options and ongoing research F Menzella, F Bertolini, M Biava, C Galeone, C Scelfo, M Caminati Drugs in context 7, 2018 | 32 | 2018 |
| ZIKV infection induces an inflammatory response but fails to activate types I, II, and III IFN response in human PBMC F Colavita, V Bordoni, C Caglioti, M Biava, C Castilletti, L Bordi, S Quartu, ... Mediators of inflammation 2018, 2018 | 30 | 2018 |
| Evaluation of a rapid and sensitive RT-qPCR assay for the detection of Ebola Virus M Biava, F Colavita, A Marzorati, D Russo, D Pirola, A Cocci, A Petrocelli, ... Journal of virological methods 252, 70-74, 2018 | 27 | 2018 |
| Deep sequencing of RNA from blood and oral swab samples reveals the presence of nucleic acid from a number of pathogens in patients with acute Ebola virus disease and is … MW Carroll, S Haldenby, NY Rickett, B Pályi, I Garcia-Dorival, X Liu, ... MSphere 2 (4), 10.1128/mspheredirect. 00325-17, 2017 | 27 | 2017 |
| Measles cases during ebola outbreak, West Africa, 2013–2106 F Colavita, M Biava, C Castilletti, S Quartu, F Vairo, C Caglioti, C Agrati, ... Emerging Infectious Diseases 23 (6), 1035, 2017 | 26 | 2017 |
| Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors? F Menzella, M Biava, D Bagnasco, C Galeone, A Simonazzi, P Ruggiero, ... Drugs in Context 8, 2019 | 25 | 2019 |
| Virological characterization of the first 2 COVID-19 patients diagnosed in Italy: phylogenetic analysis, virus shedding profile from different body sites, and antibody response … F Colavita, D Lapa, F Carletti, E Lalle, F Messina, M Rueca, G Matusali, ... Open Forum Infectious Diseases 7 (10), ofaa403, 2020 | 21 | 2020 |
| Pharmacologicaltreatment of COVID-19: lights and shadows F Menzella, M Biava, C Barbieri, F Livrieri, N Facciolongo Drugs in context 9, 2020 | 17 | 2020 |
| Detection of viral RNA in tissues following plasma clearance from an Ebola virus infected patient M Biava, C Caglioti, L Bordi, C Castilletti, F Colavita, S Quartu, E Nicastri, ... PLoS pathogens 13 (1), e1006065, 2017 | 16 | 2017 |
| EBOLA Ag K-SeT rapid test: field evaluation in Sierra Leone F Colavita, M Biava, P Mertens, Q Gilleman, C Borlon, MD Guanti, ... Clinical Microbiology and Infection 24 (6), 653-657, 2018 | 13 | 2018 |
| Persistence of ZIKV-RNA in the cellular fraction of semen is accompanied by a surrogate-marker of viral replication. Diagnostic implications for sexual transmission M Biava, C Caglioti, C Castilletti, L Bordi, F Carletti, F Colavita, S Quartu, ... New Microbiol 41 (1), 30-3, 2018 | 13 | 2018 |
| Temporary neurocognitive impairment with Ebola virus E Nicastri, P Balestra, M Ricottini, N Petrosillo, A Di Caro, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (12), 1386-1387, 2016 | 12 | 2016 |
| Pulmonary involvement during the Ebola virus disease E Lalle, M Biava, E Nicastri, F Colavita, A Di Caro, F Vairo, S Lanini, ... Viruses 11 (9), 780, 2019 | 11 | 2019 |
| INMI/Emergency NGO Italian laboratory established in Sierra Leone during Ebola virus disease outbreak in West Africa F Colavita, C Venditti, A Vulcano, C Castilletti, P Zaccaro, A Mazzarelli, ... infection 1, 2, 2016 | 6 | 2016 |
| Lazzaro Spallanzani Institute for Research and Health Care Ebola Virus Disease Sierra Leone Study Group. Measles Cases during Ebola Outbreak, West Africa, 2013-2106 F Colavita, M Biava, C Castilletti, S Quartu, F Vairo, C Caglioti, C Agrati, ... Emerg Infect Dis 23 (6), 1035-1037, 2017 | 5 | 2017 |
| Deep sequencing of RNA from blood and oral swab samples reveals the presence of nucleic acid from a number of pathogens in patients with acute Ebola virus disease and is … MW Carroll, S Haldenby, NY Rickett, B Palyi, I Garcia-Dorival, X Liu, ... RNA sequencing detects the molecular footprints of an array of pathogens …, 2017 | 5 | 2017 |
| In vitro Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2 G Sberna, M Biagi, G Marafini, R Nardacci, M Biava, F Colavita, P Piselli, ... Frontiers in microbiology 13, 799546, 2022 | 4 | 2022 |
| Enabling Rapid Response to the 2014-2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro Spallanzani. IG Nicastri E, Castilletti C, Biava M, Fusco FM, Petrosillo N, Puro V ... Adv Exp Med Biol., 2016 | 4* | 2016 |
